Hematology
Credibility 80
Kidney Function Decline in Sickle Cell Disease: Associations with Renin-Angiotensin System Inhibitors.
May 1, 2026 · Kidney360
Key takeaway
This study suggests that common blood pressure medicines (RASi) don't slow kidney damage in Black adults with sickle cell disease. This is important because sickle cell often harms kidneys, so we urgently need new ways to protect them.
Why this matters for our communities
Research in hematology helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Hematology
October 13, 2026Arginine Therapy for Sickle Cell Disease Acute Pain Episodes: The STArT Randomized Clinical Trial.Read August 24, 2026Experiences of family building counseling and perceptions of reproductive technology among adults with sickle cell disease.Read August 20, 2026Risk of infertility among women with sickle cell disease.Read